Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers

(2015) Rainer Kraehenmann et al.   BIOLOGICAL PSYCHIATRY

Ketamine interactions with biomarkers of stress: A randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men

(2015) Najmeh Khalili-Mahani et al.   NEUROIMAGE

(S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling

(2015) Ronald Sladky et al.   NEUROIMAGE

Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats

(2015) Oliver Grimm et al.   PSYCHOPHARMACOLOGY

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder

(2015) J W Murrough et al.   Translational Psychiatry

Multistage drug effects of ketamine in the treatment of major depression

(2014) Martin Walter et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Impact of acute administration of escitalopram on the processing of emotional and neutral images: a randomized crossover fMRI study of healthy women

(2014) Tim Outhred et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

(2013) James W. Murrough et al.   AMERICAN JOURNAL OF PSYCHIATRY

Functional connectivity between the amygdala and prefrontal cortex in medication-naive individuals with major depressive disorder

(2013) Lingtao Kong et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Effects of citalopram and escitalopram on fMRI response to affective stimuli in healthy volunteers selected by serotonin transporter genotype

(2013) Michael E. Henry et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Functional Neuroimaging of Major Depressive Disorder: A Meta-Analysis and New Integration of Baseline Activation and Neural Response Data

(2012) J. Paul Hamilton et al.   AMERICAN JOURNAL OF PSYCHIATRY

Ketamine for Depression: Where Do We Go from Here?

(2012) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

(2012) Michael Kometer et al.   BIOLOGICAL PSYCHIATRY

Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers

(2012) S. De Simoni et al.   NEUROIMAGE

Regional brain responses to pleasant and unpleasant IAPS pictures: Different networks

(2012) Faten M. Aldhafeeri et al.   NEUROSCIENCE LETTERS

Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action

(2012) Milan Scheidegger et al.   PLoS One

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

(2012) R. S. Duman et al.   SCIENCE

Amygdala hyperactivation and prefrontal hypoactivation in subjects with cognitive vulnerability to depression

(2011) Mingtian Zhong et al.   BIOLOGICAL PSYCHOLOGY

Antidepressant medications reduce subcortical–cortical resting-state functional connectivity in healthy volunteers

(2011) Ciara McCabe et al.   NEUROIMAGE

REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing

(2011) Xiao-Wei Song et al.   PLoS One

Relationship Between Amygdala Responses to Masked Faces and Mood State and Treatment in Major Depressive Disorder

(2010) Teresa A. Victor et al.   ARCHIVES OF GENERAL PSYCHIATRY

Brain effects of antidepressants in major depression: A meta-analysis of emotional processing studies

(2010) Pauline Delaveau et al.   JOURNAL OF AFFECTIVE DISORDERS

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance

(2010) Luiz Pessoa et al.   NATURE REVIEWS NEUROSCIENCE

Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals

(2010) Hein J.F. van Marle et al.   NEUROIMAGE

Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

(2010) Giacomo Salvadore et al.   NEUROPSYCHOPHARMACOLOGY

Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response

(2010) Diego A Pizzagalli   NEUROPSYCHOPHARMACOLOGY

Affective Cognition and its Disruption in Mood Disorders

(2010) Rebecca Elliott et al.   NEUROPSYCHOPHARMACOLOGY

Stuck in a rut: rethinking depression and its treatment

(2010) Paul E. Holtzheimer et al.   TRENDS IN NEUROSCIENCES

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity

(2009) Shinpei Yoshimura et al.   JOURNAL OF AFFECTIVE DISORDERS

Ketamine and the next generation of antidepressants with a rapid onset of action

(2009) Rodrigo Machado-Vieira et al.   PHARMACOLOGY & THERAPEUTICS

The Evolution of the Cognitive Model of Depression and Its Neurobiological Correlates

(2008) Aaron T. Beck   AMERICAN JOURNAL OF PSYCHIATRY

Neural Substrates of Increased Memory Sensitivity for Negative Stimuli in Major Depression

(2008) J. Paul Hamilton et al.   BIOLOGICAL PSYCHIATRY

Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine

(2008) Giacomo Salvadore et al.   BIOLOGICAL PSYCHIATRY